Shaperon (XKRX:378800) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:378800 Shaperon Inc XKRX:378800
31 GF Score
Price ₩514.00
GF Value ₩4,390.37
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Shaperon Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shaperon's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XKRX:378800 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Shaperon's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shaperon Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shaperon's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Shaperon's Margin of Safety % (DCF Earnings Based) falls into.


XKRX:378800
31GF Score
Shaperon Inc XKRX:378800
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shaperon (XKRX:378800) Overvalued in 2026?

Based on GuruFocus' analysis, Shaperon stock appears to be undervalued. The current stock price of ₩514.00 is trading 88.3% below its estimated GF Value™ of ₩4,390.37. GuruFocus considers Shaperon to be Possible Value Trap.

Key valuation signals for XKRX:378800:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₩4,390.37 vs. price of ₩514.00 (88.3% below fair value)
  • GF Score™: 31/100 with 6 warning signs

No single metric tells the full story. See the XKRX:378800 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shaperon Business Description

Address Gangnam Ace Tower G9, Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu, Seoul, KOR, 06373
Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.
31GF Score

Get the complete analysis for XKRX:378800

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩514.00
Price
₩4,390.37
GF Value